Key Metrics
6.2
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.001 - 0.005
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
Q2
Genetics
SJR
- Q2 Genetics
- Q2 Biochemistry
- Q2 Cancer Research
- Q2 Molecular Biology
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
0.94
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Topics Covered
- Hepatocellular carcinoma
- Genotype
- Colorectal cancer
- Medulloblastoma
- Vector control
- Histone deacetylase
- Prostate cancer
- Extracellular vesicles
- Renal carcinoma
- Overall survival
- Immunohistochemistry
- Substrate-level phosphorylation
- Gene expression
- Breast cancer
- Conditioned medium
- Senescence
- Fusion gene
- Betel quid chewing
- Xeroderma pigmentosum
- Androgen receptor
Journal Specifications
| Overview | |
| Publisher | INT INST ANTICANCER RESEARCH |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2004 |
| Website URL | Visit website |
Planning to publish in Cancer Genomics and Proteomics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Sex Hormone-regulated<i>CMG2</i>Is Involved in Breast and Prostate Cancer Progression
- 1 Jan 22
- Cancer Genomics - Proteomics
-
Full paper
Disruption of Lipid Raft Microdomains, Regulation of CD38, TP53, and MYC Signaling, and Induction of Apoptosis by Lomitapide in Multiple Myeloma Cells
- 1 Jan 22
- Cancer Genomics - Proteomics
-
Full paper
Presence of a t(12;18)(q14;q21) Chromosome Translocation and Fusion of the Genes for High-mobility Group AT-Hook 2 (<i>HMGA2</i>) and WNT Inhibitory Factor 1 (<i>WIF1</i>) in Infrapatellar Fat Pad Cells from a Patient With Hoffa’s Disease
- 1 Jan 22
- Cancer Genomics - Proteomics
-
Full paper
Artesunate-induced Cellular Effects Are Mediated by Specific EPH Receptors and Ephrin Ligands in Breast Carcinoma Cells
- 23 Dec 21
- Cancer Genomics - Proteomics
-
Full paper
Salivary<i>CCL20</i>Level as a Biomarker for Oral Squamous Cell Carcinoma
- 19 Feb 21
- Cancer Genomics - Proteomics
-
Full paper
Effect of HPV 16 E6 Oncoprotein Variants on the Alterations of the Proteome of C33A Cells
- 1 Jan 21
- Cancer Genomics - Proteomics
Scite analysis
Powered by scite_
438 articles received 3.6k citations see all
- 129 Supporting
- 3,411 Mentioning
- 14 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 0 Corrections
- 0 Errata
- 0 Expression of Concern
FAQs
How long has Cancer Genomics and Proteomics been actively publishing?
Cancer Genomics and Proteomics has been in operation since 2004 till date.
What is the publishing frequency of Cancer Genomics and Proteomics ?
Cancer Genomics and Proteomics published with a Bi-monthly frequency.
How many articles did Cancer Genomics and Proteomics publish last years ?
In 2023, Cancer Genomics and Proteomics published articles.
What is the eISSN & pISSN for Cancer Genomics and Proteomics ?
For Cancer Genomics and Proteomics,eISSN is 1790-6245 and pISSN is1109-6535.
What is Citescore for Cancer Genomics and Proteomics ?
Citescore for Cancer Genomics and Proteomics is 6.2.
What is SNIP score for Cancer Genomics and Proteomics ?
SNIP score for Cancer Genomics and Proteomics is 0.94.
What is the SJR for Cancer Genomics and Proteomics ?
SJR for Cancer Genomics and Proteomics is Q2.
Who is the publisher of Cancer Genomics and Proteomics ?
INT INST ANTICANCER RESEARCH is the publisher of Cancer Genomics and Proteomics.